Josh Plotnik

Josh Plotnik, Ph.D., is a Principal Research Scientist in Oncology Discovery Research at AbbVie, where they focus on new target identification and validation. With a career at AbbVie spanning from 2020 to the present, Josh has held various roles, including Senior Scientist II and Senior Scientist I, and previously worked as a Postdoctoral Fellow in Translational Oncology. Their academic journey includes earning a Ph.D. in Genome, Cellular, and Developmental Biology from Indiana University and a B.S. in Biological Sciences from Carnegie Mellon University. Josh is proficient in multi-omic platforms for identifying vulnerabilities for targeted therapies and leads cross-functional drug discovery initiatives.